Professional Advisory Services’s Charles River Laboratories CRL Stock Holding History

Professional Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-73,040	Closed	-$14.4M	–	79
2024 Q3	$14.4M	Buy	73,040 +8,936	+14%	+$1.86M	1.89%	29
2024 Q2	$13.2M	Buy	64,104 +9,008	+16%	+$2.04M	1.81%	31
2024 Q1	$14.9M	Sell	55,096 -10,533	-16%	-$2.52M	2.03%	29
2023 Q4	$15.5M	Buy	65,629 +3,487	+6%	+$686K	2.22%	28
2023 Q3	$12.2M	Buy	62,142 +2,597	+4%	+$533K	2%	28
2023 Q2	$12.5M	Buy	+59,545	New	+$11.8M	1.9%	30

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Professional Advisory Services's CRL Position: Q4 2024 in Review

Professional Advisory Services sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 73,040 shares — an estimated $14.4M sold.

Professional Advisory Services first reported a position in CRL in Q2 2023 and held it in 6 quarters. The position peaked at $15.5M in Q4 2023. 635 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

Professional Advisory Services reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
Professional Advisory Services sold 73,040 Charles River Laboratories shares in Q4 2024, an estimated $14.4M.
Professional Advisory Services first reported a position in Charles River Laboratories in Q2 2023 and held it in 6 quarters.
Professional Advisory Services's Charles River Laboratories position peaked at $15.5M in Q4 2023.
635 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Professional Advisory Services's 13F filing for Q4 2024, filed 15 Jan 2025.